Laeknas R&D Focus: A Broad-Based Strategy Targeting ActRII The most closely watched domestically developed candidate for fat loss with muscle gain is LAE102, an ActRIIA-targeting antibody developed by Laekna Therapeutics
Giacomini KM, Huang SM, Tweedie DJ et al (2010) Membrane transporters in drug development
Continuous glucose monitoring, if available, helps track the pace of improvement
In an assessment of more than 170,000 patients, GLP-1 drugs were not linked with higher cancer rates, and led to a decrease in obesity-related cancers and deaths, according to a study presented during the 2025 American Society of Clinical Oncology Annual Meeting
Heart Health L-carnitine plays a vital role in the metabolism of fatty acids, essential for heart muscle energy production
Sithole et al